NDC properties for "Neo-Predef (isoflupredone acetate 1 MG / neomycin 3.5 MG (as neomycin sulfate 5 MG) / tetracaine hydrochloride 5 MG) per 1 GM Topical Powder" (RxCUI 1551417)
About this data
The tables show NDC propoerties for Neo-Predef (isoflupredone acetate 1 MG / neomycin 3.5 MG (as neomycin sulfate 5 MG) / tetracaine hydrochloride 5 MG) per 1 GM Topical Powder with the RxCUI 1551417
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Neo-Predef (isoflupredone acetate 1 MG / neomycin 3.5 MG (as neomycin sulfate 5 MG) / tetracaine hydrochloride 5 MG) per 1 GM Topical Powder (RxCUI 1551417)
| NADA | NADA015433 |
|---|---|
| RxCUI | 1551417 |
| SPL_SET_ID | 5de35de9-7db4-49da-be31-6788fe8558e4 |
| Prescribable Synonym | Neo-Predef 0.001 MG/MG / 0.0035 MG/MG / 0.005 MG/MG Topical Powder |
| RXNAV_STR | Neo-Predef (isoflupredone acetate 1 MG / neomycin 3.5 MG (as neomycin sulfate 5 MG) / tetracaine hydrochloride 5 MG) per 1 GM Topical Powder |
| RxNorm Name | isoflupredone acetate 0.001 MG/MG / neomycin 0.0035 MG/MG / tetracaine hydrochloride 0.005 MG/MG Topical Powder [Neo-Predef] |
| RxNorm Synonym | Neo-Predef (isoflupredone acetate 1 MG / neomycin 3.5 MG (as neomycin sulfate 5 MG) / tetracaine hydrochloride 5 MG) per 1 GM Topical Powder |
| Related queries | Interactions (for RxCUI 1551417) |
NDC Properties
NDC Item 54771158401
| NDC 9 | 54771-1584 |
|---|---|
| NDC 10 | 54771-1584-1 |
| NDC Item | 54771158401 |
| Packaging | 15 g in 1 BOTTLE (54771-1584-1) |
| FDA SPL set id | 516555 |
| Labeler | Zoetis Inc. |
| Label type | PRESCRIPTION ANIMAL DRUG |
| Marketing category | NADA |
| Marketing effective time low | 1965-01-13 |
| Marketing status | ACTIVE |
| NADA | NADA015433 |
| Related queries | Properties for NDC 9 54771-1584 |